Category: Cardiac Rhythm Management
A $7 million funding round for Cardiac Insight, 1st reported by MassDevice.com, was led by Welch Allyn and includes exclusive global distribution rights, the companies said yesterday.
A Danish study of St. Jude Medical's recalled Riata and Riata ST defibrillator leads suggests that the externalization problem that led to the recall worsens over time and is linked to "electrical abnormalities."
St. Jude Medical's 2nd-quarter results, including a 2% gain for its implantable cardiac defibrillator business, could signal a rebound for the ICD sector overall, according to Leerink Partners.
Kevin King, CEO of Silicon Valley digital health company iRhythm, tells MassDevice about the promise of Big Data and how remote patient monitoring can reveal intricate details of the habits of the heart.
Digital health is all the rage in Silicon Valley, especially as consumer technology's biggest players are getting more interested in tracking health and fitness. But for companies like iRhythm, the health side of the equation comes first.
A federal judge rules that most of the product liability claims against St. Jude Medical are preempted in a trio of lawsuits filed over its recalled Riata defibrillator leads.
St. Jude Medical says the FDA cleared the Sylmar, Calif., plant that produces its Durata defibrillators leads following a warning letter issued early last year.
Medtronic unveils early results from the 1st patients implanted with the pill-sized Micra pacemaker and Sorin shows that its 'SafeR' mode of pacing prevents unnecessary shocks.